RVNC
Revance Therapeutics Inc
Price:  
2.82 
USD
Volume:  
1,217,879.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC WACC - Weighted Average Cost of Capital

The WACC of Revance Therapeutics Inc (RVNC) is 8.6%.

The Cost of Equity of Revance Therapeutics Inc (RVNC) is 10.95%.
The Cost of Debt of Revance Therapeutics Inc (RVNC) is 7.00%.

Range Selected
Cost of equity 7.60% - 14.30% 10.95%
Tax rate 0.10% - 0.10% 0.10%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.2% - 9.9% 8.6%
WACC

RVNC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.81 1.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 14.30%
Tax rate 0.10% 0.10%
Debt/Equity ratio 1.47 1.47
Cost of debt 7.00% 7.00%
After-tax WACC 7.2% 9.9%
Selected WACC 8.6%